OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
Eline van Overbeeke, Sissel Michelsen, Mondher Toumi, et al.
Drug Discovery Today (2020) Vol. 26, Iss. 2, pp. 399-415
Open Access | Times Cited: 34
Showing 26-50 of 34 citing articles:
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms
Casey Quinn, Michael Ciarametaro, Brian Sils, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 5, pp. 535-546
Open Access | Times Cited: 1
Casey Quinn, Michael Ciarametaro, Brian Sils, et al.
Expert Review of Pharmacoeconomics & Outcomes Research (2023) Vol. 23, Iss. 5, pp. 535-546
Open Access | Times Cited: 1
Alternative evidence in drug development and regulatory science
Nora A. Janjan, Patrick J. Silva, Kenneth S. Ramos, et al.
Elsevier eBooks (2023), pp. 180-196
Closed Access | Times Cited: 1
Nora A. Janjan, Patrick J. Silva, Kenneth S. Ramos, et al.
Elsevier eBooks (2023), pp. 180-196
Closed Access | Times Cited: 1
Can attentional nudges improve efficiency of bilateral multi-attribute negotiations?
Karine Lamiraud, Julien Patris, Radu Vranceanu
Journal of Behavioral and Experimental Economics (2024) Vol. 110, pp. 102205-102205
Open Access
Karine Lamiraud, Julien Patris, Radu Vranceanu
Journal of Behavioral and Experimental Economics (2024) Vol. 110, pp. 102205-102205
Open Access
Arzneimittelzulassung im Bereich seltener Erkrankungen: die europäische regulatorische Perspektive am Beispiel der Gen- und Zelltherapeutika
Martina Schüßler-Lenz, Benjamin Hofner
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2024) Vol. 189, pp. 73-81
Closed Access
Martina Schüßler-Lenz, Benjamin Hofner
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2024) Vol. 189, pp. 73-81
Closed Access
Desenvolvimento de carreador lipídico nanoestruturado contendo pool de siRNAs associados a agente antitumoral como uma abordagem terapêutica multifuncional para o câncer de pele
Juliana Santos Rosa Viegas
(2022)
Open Access | Times Cited: 1
Juliana Santos Rosa Viegas
(2022)
Open Access | Times Cited: 1
Experimental Evidence on the Value of Time and Structure in Market Negotiations
Karine Lamiraud, Julien Patris, Radu Vranceanu
SSRN Electronic Journal (2023)
Open Access
Karine Lamiraud, Julien Patris, Radu Vranceanu
SSRN Electronic Journal (2023)
Open Access
Experimental Evidence on the Value of Time and Structure in Market Negotiations
Karine Lamiraud, Julien Patris, Radu Vranceanu
(2023)
Open Access
Karine Lamiraud, Julien Patris, Radu Vranceanu
(2023)
Open Access
Dürfen Gentherapien so viel kosten? Ethische Bewertung der hohen Preise und des performanceorientierten Erstattungsmodells
Karla Alex, Julia König
Springer eBooks (2023), pp. 317-337
Closed Access
Karla Alex, Julia König
Springer eBooks (2023), pp. 317-337
Closed Access
Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft
Boris Fehse, Hannah Schickl, Sina Bartfeld, et al.
Springer eBooks (2023)
Closed Access
Boris Fehse, Hannah Schickl, Sina Bartfeld, et al.
Springer eBooks (2023)
Closed Access
